Impact of Burkholderia infection on lung transplantation in cystic fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 178, Issue 4, 2008, Pages 363-371

  Murray, Susan ^a,b   Charbeneau, Jeffery ^a,e   Marshall, Bruce C ^c   LiPuma, John J ^a,d  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b Scientific Registry of Transplant Recipients   (United States)

^c CYSTIC FIBROSIS FOUNDATION   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

Author keywords

Burkholderia; Infection; Lung allocation; Transplant benefit

Indexed keywords

ADULT; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA GLADIOLI; CYSTIC FIBROSIS; GRAFT RECIPIENT; HUMAN; INFECTION RISK; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SURVIVAL;

ADULT; BURKHOLDERIA INFECTIONS; CASE-CONTROL STUDIES; COHORT STUDIES; CYSTIC FIBROSIS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG TRANSPLANTATION; MALE; MULTIVARIATE ANALYSIS; PNEUMONIA, BACTERIAL; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RISK; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 48949098039     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200712-1834OC     Document Type: Article

References (43)

1. Annual report of the US Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: transplant data 1996-2005. Rockville, MD: Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2006.
2. Hosenpud JD, Bennett LE, Keck BM, Edwards EB, Novick RJ. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998;351:24-27.
3. Aurora P, Whitehead B, Wade A, Bowyer J, Whitmore P, Rees PG, Tsang VT, Elliott MJ, de Leval M. Lung transplantation and life extension in children with cystic fibrosis. Lancet 1999;354:1591-1593.
4. Liou TG, Adler FR, Huang D. Use of lung transplantation survival models to refine patient selection in cystic fibrosis. Am J Respir Crit Care Med 2005;171:1053-1059.
5. Liou TG, Adler FR, Cahill BC, FitzSimmons SC, Huang D, Hibbs JR, Marshall BC. Survival effect of lung transplantation among patients with cystic fibrosis. JAMA 2001;286:2683-2689.
6. Liou TG, Adler FR, Cox DR, Cahill BC. Lung transplantation and survival in children with cystic fibrosis. N Engl J Med 2007;357:2143-2152.
7. Egan TM, Murray S, Bustami RT, Shearon TH, McCullough KP, Edwards LB, Coke MA, Garrity ER, Sweet SC, Heiney DA, et al. Development of the new lung allocation system in the United States. Am J Transplant 2006;6:1212-1227.
8. Organ Procurement and Transplantation Network; United Network for Organ Sharing. Executive summary of the minutes OPTN/UNOS Board of Directors meeting. St. Louis, MO: Organ Procurement and Transplantation Network, United Network for Organ Sharing; 2007.
9. 2 as an allocation factor in lung transplantation. Am J Transplant 2007;7:244.
10. Griffith BP, Hardesty RL, Armitage JM, Hattler BG, Pharn SM, Keenan RJ, Paradis I. A decade of lung transplantation. Ann Surg 1993;218:310-320.
11. Kanj SS, Tapson V, Davis RD, Madden J, Browning I. Infections in patients with cystic fibrosis following lung transplantation. Chest 1997;112:924-930.
12. Kurland G, Orenstein DM. Complications of pediatric lung and heart-lung transplantation. Curr Opin Pediatr 1994;6:262-271.
13. Massard G, Shennib H, Metras D, Camboulives J, Viard L, Mulder DS, Tchervenkov CI, Morin JF, Giudicelli R, Noirclerc M. Double-lung transplantation in mechanically ventilated patients with cystic fibrosis. Ann Thorac Surg 1993;55:1087-1091.
14. Aris RM, Gilligan PH, Neuringer IP, Gott KK, Rea J, Yankaskas JR. The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome. Am J Respir Crit Care Med 1997;155:1699-1704.
15. Balfour-Lynn IM, Ryley HC, Whitehead BF. Subdural empyema due to Burkholderia cepacia: an unusual complication after lung transplantation for cystic fibrosis. J R Soc Med 1997;90:59-64.
16. Chaparro C, Chamberlain D, Maurer J, Winton T, Dehoyos A, Kesten S. Bronchiolitis obliterans organizing pneumonia (BOOP) in lung transplant recipients. Chest 1996;110:1150-1154.
17. Chaparro C, Maurer J, Gutierrez C, Krajden M, Chan C, Winton T, Keshavjee S, Scavuzzo M, Tullis E, Hutcheon M, et al. Infection with Burkholderia cepacia in cystic fibrosis. Am J Respir Crit Care Med 2001;163:43-48.
18. Noyes BE, Michaels MG, Kurland G, Armitage JM, Orenstein DM. Pseudomonas cepacia empyema necessitatis after lung transplantation in two patients with cystic fibrosis. Chest 1994;105:1888-1891.
19. Snell GI, de Hoyos A, Krajden M, Winton T, Maurer JR. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis. Chest 1993;103:466-471.
20. Egan JJ, McNeil K, Bookless B, Gould K, Corris P, Higenbottam T, Webb AK, Woodcock AA. Post-transplantation survival of cystic fibrosis patients infected with Pseudomonas cepacia. Lancet 1994;344:552-553.
21. LiPuma JJ. Burkholderia cepacia complex: a contraindication to lung transplantation in cystic fibrosis? Transpl Infect Dis 2001;3:149-160.
22. Webb AK, Egan J. Should patients with cystic fibrosis infected with Burkholderia cepacia undergo lung transplantation? Thorax 1997;52:671-673.
23. Reik R, Spilker T, LiPuma JJ. Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis. J Clin Microbiol 2005;43:2926-2928.
24. LiPuma JJ. Update on the Burkholderia cepacia complex. Curr Opin Pulm Med 2005;11:528-533.
25. LiPuma JJ, Dulaney BJ, McMenamin JD, Whitby PW, Stull TL, Coenye T, Vandamme P. Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients. J Clin Microbiol 1999;37:3167-3170.
26. Mahenthiralingam E, Bischof J, Byrne SK, Radomski C, Davies JE, Av-Gay Y, Vandamme P. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol 2000;38:3165-3173.
27. Coenye T, Spilker T, Martin A, LiPuma JJ. Comparative assessment of genotyping methods for epidemiologic study of Burkholderia cepacia genomovar III. J Clin Microbiol 2002;40:3300-3307.
28. Cox DR. Regression models and life tables. J Roy Stat Soc[Ser A] 1972;34:187-220.
29. 1 may adversely affect overall survival. Chest 1999;115:782-787.
30. Mariencheck WI Jr, Palmer SM, Tapson VF, Davis RD, Durham NC. Survival following lung transplantation of cystic fibrosis patients colonized with Burkholderia cepacia [abstract]. Am J Respir Crit Care Med 2000;161:A720.
31. De Soyza A, McDowell A, Archer L, Dark JH, Elborn SJ, Mahenthiralingam E, Gould K, Corris PA. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 2001;358:1780-1781.
32. Aris RM, Routh JC, LiPuma JJ, Heath DG, Gilligan PH. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex: survival linked to genomovar type. Am J Respir Crit Care Med 2001;164:2102-2106.
33. McMenamin JD, Zaccone TM, Coenye T, Vandamme P, LiPuma JJ. Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates. Chest 2000;117:1661-1665.
34. Chen JS, Witzmann KA, Spilker T, Fink RJ, LiPuma JJ. Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis. J Pediatr 2001;139:643-649.
35. Coenye T, LiPuma JJ. Population structure analysis of Burkholderia cepacia genomovar III: varying degrees of genetic recombination characterize major clonal complexes. Microbiology 2002;149:77-88.
36. Jones AM, Dodd ME, Govan JR, Barcus V, Doherty CJ, Morris J, Webb AK. Burkholderia cenocepacia and Burkholderia multivorans: Influence on survival in cystic fibrosis. Thorax 2004;59:948-951.
37. Ledson MJ, Gallagher MJ, Jackson M, Hart CA, Walshaw MJ. Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre. Thorax 2002;57:142-145.
38. Khan SU, Gordon SM, Stillwell PC, Kirby TJ, Arroliga AC. Empyema and bloodstream infection caused by Burkholderia gladioli in a patient with cystic fibrosis after lung transplantation. Pediatr Infect Dis J 1996;15:637-639.
39. Jones AM, Stanbridge TN, Isalska BJ, Dodd ME, Webb AK. Burkholderia gladioli: recurrent abscesses in a patient with cystic fibrosis. J Infect 2001;42:69-71.
40. Kennedy MP, Coakley RD, Donaldson SH, Aris RM, Hohneker K, Wedd JP, Knowles MR, Gilligan PH, Yankaskas JR. Burkholderia gladioli: five year experience in a cystic fibrosis and lung transplantation center. J Cyst Fibros 2007;6:267-273.
41. Govan JR, Brown AR, Jones AM. Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection. Future Microbiol 2007;2:153-164.
42. Segonds C, Heulin T, Marty N, Chabanon G. Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates. J Clin Microbiol 1999;37:2201-2208.
43. Whiteford ML, Wilkinson JD, McColl JH, Conlon FM, Michie JR, Evans TJ, Paton JY. Outcome of Burkholderia (Pseudomonas) cepacia colonization in children with cystic fibrosis following a hospital outbreak. Thorax 1995;50:1194-1198.